The guides on how to reconstitute semaglutide and how to reconstitute tirzepatide walk through the process step by step
The increase in release is decreased in T2DM, which deteriorates the GLP-1 effect, which impairs insulin secretion and results in insulin resistance and hyperglycemia
The legal and health risks are not worth it
However, weight loss itself increases the risk of gallbladder disease, so its hard to be sure that its the semaglutide thats causing the issue
However, the effects do not last long, and it may lead to stress reactions, requiring multiple injections in a short time, which is time-consuming and expensive
Ongoing studies are evaluating cardiovascular outcomes with tirzepatide in populations with overweight/obesity and T2D (SURPASS-CVOT) and in those with obesity but without diabetes (SURMOUNT-MMO) [28, 29]